"NexTech AR (@NexTech_AR) (#OTCQB: $NEXCF | #CSE: $NTAR) To Launch New #3D-#AR-360 Ad Network [https://t.co/O0R5nsG8yS]#investing #stocks #stockmarket #trading #investors #news #investing #business #investments #tech #technology #VR #virtualreality #augmentedreality"Read full newsRead More
"Yield Growth (@yieldgrowth) (#CSE: $BOSS | #OTCQB: $BOSQF) Signs Definitive Agreement with Green Space Worldwide to Market @UrbanJuve [https://t.co/vbRSIoTFCi]#investing #stocks #stockmarket #trading #investors #cannabisnews #capitalmarkets #business #potstocks #cannabis #CBD"Read full newsRead More
"Talisker Provides Phase 1 Exploration Update, Increases Number of Anomalous Gold Basins to 22, Defines 8 Clear Phase 2 Targets https://t.co/gg2d2xFWHz #ResourceNews #Gold $TSK"Read full newsRead More
"@GrantMBeasley Good sign! Goldman just recommenced $ALB and $LTHM as contracyclical opportunities to their top clients. Even the biggest Lithium bear, Morgan Stanley, sent out a strong report about stellar EV growth. Smart money is accumulating/positioning for the next wave? #lithium"Read full newsRead More
Sally Beauty has been suffering long term on the chartsShares of Sally Beauty Holdings, Inc. (NYSE:SBH) are down 1.2% at $16.20 this afternoon, reversing course after two-day climb up the charts, and a recent lift off their early September lows. Today's pullback may not be one-off, however, as data from Schaeffer's Senior Quantitative Analyst Rocky White, suggests a long-term bear signal may be f...Read More
Great Bear reported its intention to create and spin-out a two percent Net Smelter Royalty on potential future mineral production at the Dixie property.Read full newsRead More
"This is a #GameChanger for $EXM.C!This license now opens the door to European #CBD distribution (#HugeNews) and solidifys the acquisition of the Malawi property for cannabis and hemp cultivation! ??~(R)#EXMceuticals #CBD #MedicalCannabis #AfricaPartnership https://t.co/bJOnzT7bez"Read full newsRead More
Montr?(C)al, QC - Siyata Mobile Inc. (TSX-V:SIM | OTCQX: SYATF) (the "Company" or "Siyata") is pleased to announce it has launched the Company's flagship Push-to-Talk LTE Uniden (R) UV350 in-vehicle device that is integrated with Nova Talk, a leading enterprise PoC solution for instant communication.The UV350 provides its enterprise customers with the first ever dedicated in-vehicle Push-to-...Read More
In our latest Insights newsletter, we compare the case for gloom with what's needed to keep going with the asset price boom. Our broadcast of the week is showdown between a champion for bitcoin and a champion for gold. Meanwhile, our insider of the week has paved the way for the Trans Mountain Expansion project to proceed. Read the latest Canadian Insider Insights here. Read More
3M's earnings report is weighing on the DowThe Dow Jones Industrial Average (DJI) is lower at midday, but has pared a triple-digit deficit at its session lows, as a dismal earnings report from 3M (MMM) offsets well-received quarterly reports from Microsoft (MSFT) and Dow Inc (DOW). The S&P 500 Index (SPX) is sitting just above breakeven, while the Nasdaq Composite (IXIC) is confidently higher...Read More
Facebook and Alphabet will also report earnings Traders are gearing up for another busy few days of earnings, with Apple's (AAPL) quarterly report due right in the middle of the week. Fellow tech concerns Alphabet (GOOGL) and Facebook (FB) are also set to release their numbers, while reports from names like Merck (MRK) and Bristol-Myers Squibb (BMY) will put the healthcare sector in focus. The eco...Read More
Analysts are calling Neovasc and PDS Biotechnology a "buy"Penny stocks Neovasc Inc (NASDAQ:NVCN) and PDS Biotechnology Corp (NASDAQ:PDSB) are both on analysts' radars today, and soaring as a result. Specifically, H.C. Wainwright initiated coverage on Neovasc with a "buy" rating and a price target of $9 -- almost triple yesterday's close at $3.61. Likewise, Chardan initiated coverage on PDS Biotech...Read More
The study has 19 previous examples to take from, tooUnion Pacific Corporation (NYSE:UNP) has been strong in recent weeks, and today the shares have moved above the $170 level, last seen up 0.2% at $170.45. From a longer-term perspective, the stock recently pulled back to the 10-month moving average, which historically been a good time to go bullish on the freight concern. Schaeffer's Senior Quanti...Read More
A lawsuit filed by an Australian woman claims that a group of dingoes attacked her after she tried to retrieve the phone one of the animals had snatched from her hands as she ate lunch.Read full newsRead More
Draya Michele's clothing line with superdown is guaranteed to sell out. Find out all of the details on the influencer-approved affordable clothing collection.Read full newsRead More
J.P. Morgan Securities downgraded the stock to "underweight"Shares of Acorda Therapeutics Inc (NASDAQ:ACOR) are plunging this morning, already down 13.9% to trade at $2.33. Acorda issued a double-whammy last night,sharing its corporate restructuring plan -- which includes a 25% cut to its workforce -- and unveiling lackluster third-quarter sales of Inbrija, its Parkinson's drug. As such, ACOR was...Read More
TSLA is on track for its best day since January 2012One of the top earnings winners this morning is Tesla Inc (NASDAQ:TSLA). The electric car concern reported adjusted third-quarter earnings of $1.86 per share, blowing past the estimated loss of 42 cents per share. The surprise profit beat was enough to overshadow a revenue miss, while CEO Elon Musk detailed a cheaper SUV rollout and revealed Tes...Read More
eBay predicted weaker-than-expected revenue for its fourth quarter The shares of eBay Inc (NASDAQ:EBAY) are eyeing four-month lows today, following a sub-par earnings report. While its reported earnings per share of 67 centsand $2.65 billion in revenue beat analyst estimates, the e-tailer predicted weaker-than-expected revenue for the holiday quarter. The forecast has analysts swarming thestock. S...Read More
Baird analysts are moving to the sidelines on ARWRGene silencing expert Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) has been a major winner in 2019. The shares are up more than 200% year-to-date and have added 41% in the past month alone, while yesterday touching their highest point in almost 12 years. However, one brokerage firm is telling investors it's time to move to the sidelines on ARWR stoc...Read More
NOK hit a six-year low out of the gateNokia Oyj (NYSE:NOK) stock has plunged 21.3% to trade at $4.02 -- earlier hitting a six-year low of $3.98 -- after the Finnish telecom network equipment maker cut its 2019 and 2020 profit guidance, citing rising costs associated with 5G technology and margin pressures. NOK also said it will temporarily suspend its dividend payment until its cash flow stabilize...Read More